|
JPS5396311A
(en)
*
|
1977-01-29 |
1978-08-23 |
Toyama Chem Co Ltd |
Anti-cander drugs containing lysolecithins
|
|
JPS5528955A
(en)
*
|
1978-08-24 |
1980-02-29 |
Toyama Chem Co Ltd |
Novel glycerophosphoric acid derivative, its salt, their preparation, and carcinostatic agent containing the same.
|
|
GB2046092B
(en)
|
1979-03-05 |
1983-11-02 |
Toyama Chemical Co Ltd |
Pharmaceutical composition containing a lysophospholid and a phospholipid
|
|
US4408052A
(en)
*
|
1980-02-27 |
1983-10-04 |
Takeda Chemical Industries, Ltd. |
Phospholipid carbamates
|
|
US4551532A
(en)
*
|
1980-05-08 |
1985-11-05 |
Takeda Chemical Industries, Ltd. |
Ethylene glycol derivatives having anti-protozoan, anti-fungal and anti-tumor activity
|
|
EP0050327B1
(de)
*
|
1980-10-21 |
1984-06-20 |
Roche Diagnostics GmbH |
Neue schwefelhaltige Phospholipide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
JPS5772914A
(en)
*
|
1980-10-22 |
1982-05-07 |
Takeda Chem Ind Ltd |
Antitumor agent
|
|
EP0061872B1
(en)
*
|
1981-03-30 |
1985-08-07 |
Takeda Chemical Industries, Ltd. |
Ethyleneglycol derivatives, their production and use
|
|
DE3127503A1
(de)
*
|
1981-07-11 |
1983-02-17 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Neue phospholipide, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
|
|
DE3131524A1
(de)
*
|
1981-08-08 |
1983-02-24 |
Röhm GmbH, 6100 Darmstadt |
Verfahren zur herstellung physiologischer effektoren
|
|
US4562179A
(en)
*
|
1982-04-19 |
1985-12-31 |
Fujisawa Pharmaceutical Co., Ltd. |
Phospholipid derivatives, and pharmaceutical composition of the same
|
|
DE3239858A1
(de)
*
|
1982-07-06 |
1984-01-12 |
Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen |
Neue d-mannitderivate als ausgangsprodukte zur synthese von phospholipiden
|
|
DE3239817A1
(de)
*
|
1982-07-06 |
1984-01-12 |
Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen |
Neue glycerinderivate zur synthese von phospholipiden
|
|
DE3368933D1
(en)
*
|
1982-09-21 |
1987-02-12 |
Fujisawa Pharmaceutical Co |
Phosphate derivatives, process for preparation thereof and pharmaceutical compositions of the same
|
|
US4710579A
(en)
*
|
1984-11-09 |
1987-12-01 |
Takeda Chemical Industries, Ltd. |
2-(acetoacetyloxy)-3-(octadecyloxy)propyl-3-trimethylammoniopropyl phosphate or a pharmaceutically acceptable salt thereof
|
|
US4761404A
(en)
*
|
1985-07-01 |
1988-08-02 |
Merck & Co., Inc. |
Phospholipid analogs useful as PAF synthesis inhibitors
|
|
EP0209239B1
(en)
|
1985-07-15 |
1989-03-01 |
Takeda Chemical Industries, Ltd. |
2-alkanoyloxypropane derivatives, their production and use
|
|
JPS6294A
(ja)
*
|
1986-05-09 |
1987-01-06 |
Toyama Chem Co Ltd |
新規なグリセロリン酸誘導体およびその塩並びにそれらの製造法
|
|
JP2561478B2
(ja)
*
|
1986-07-22 |
1996-12-11 |
武田薬品工業株式会社 |
グリセリン誘導体
|
|
US4888328A
(en)
*
|
1988-03-10 |
1989-12-19 |
Hoeschst-Roussel Incorporated |
Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
|
|
US5036152A
(en)
*
|
1988-03-10 |
1991-07-30 |
Hoechst-Roussel Pharmaceuticals Incorporated |
Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
|
|
DE3906952A1
(de)
*
|
1989-03-04 |
1990-09-06 |
Boehringer Mannheim Gmbh |
(3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
|
|
DE3918082A1
(de)
*
|
1989-06-02 |
1991-01-24 |
Max Planck Gesellschaft |
Mittel gegen autoimmunerkrankungen
|
|
DE3935580C2
(de)
*
|
1989-10-25 |
1998-05-28 |
Medmark Pharma Gmbh |
Verwendung eines pharmazeutischen Wirkstoffes zur Behandlung von HIV-Infektionen
|
|
EP0581793A1
(en)
*
|
1991-04-25 |
1994-02-09 |
University Of British Columbia |
Phosphonates and phosphinates as anti-cancer, -inflammatory, -allergy and -myocarditis agents
|
|
ES2034885B1
(es)
*
|
1991-07-10 |
1994-03-01 |
Menarini Lab |
Procedimiento para la preparacion de cetoalquilglicerofosfolipidos.
|
|
EP0785773B1
(en)
*
|
1994-10-14 |
2001-01-03 |
The Liposome Company, Inc. |
Ether lipid liposomes and their therapeutic use
|
|
US5965159A
(en)
|
1996-02-16 |
1999-10-12 |
The Liposome Company, Inc. |
Etherlipid-containing multiple lipid liposomes
|
|
US6007839A
(en)
*
|
1996-02-16 |
1999-12-28 |
The Liposome Company, Inc. |
Preparation of pharmaceutical compositions containing etherlipid-containing multiple lipid liposomes
|
|
US5942246A
(en)
*
|
1996-02-16 |
1999-08-24 |
The Liposome Company, Inc. |
Etherlipid containing multiple lipid liposomes
|
|
US6667053B1
(en)
|
1996-02-16 |
2003-12-23 |
Elan Pharmaceuticals, Inc. |
D and L etherlipid stereoisomers and liposomes
|
|
USRE39042E1
(en)
*
|
1996-02-16 |
2006-03-28 |
The Liposome Company, Inc. |
Etherlipid-containing multiple lipid liposomes
|
|
US6135426A
(en)
*
|
1998-01-07 |
2000-10-24 |
Briggs And Stratton Corporation |
Priming system for internal combustion engines
|
|
AU2007316587B2
(en)
|
2006-11-10 |
2013-10-31 |
Cellprotect Patent Ag |
Methods and compositions for detecting receptor ligand mimetics
|
|
CN103816127A
(zh)
|
2006-11-10 |
2014-05-28 |
阿尔法普托斯有限公司 |
含有三取代甘油化合物的口服剂型
|
|
WO2008074573A1
(en)
*
|
2006-12-20 |
2008-06-26 |
Alphaptose Gmbh |
Topical dosage form comprising tri-substituted glycerol compounds
|
|
RU2474427C2
(ru)
*
|
2006-12-20 |
2013-02-10 |
Универзитетсклиникум Хамбург-Эппендорф |
Применение тризамещенных соединений глицерина для лечения гематологических злокачественных опухолей
|
|
WO2013156630A1
(en)
|
2012-04-20 |
2013-10-24 |
Alphaptose Gmbh |
S-enantiomer of a tri-substituted glycerol compound
|